Tumor cells that overexpress ErbB2 exhibit uncontrolled proliferation due to ligand-independent heterodimerization of ErbB2 and ErbB3 and the activation of downstream intracellular phosphoinositide-3-kinase (PIK3) and Akt signaling pathways. Here, ERBB2 is linked to neoplasm.